Cargando…

Neutrophil-lymphocyte ratio change after curative gastrectomy for gastric cancer: a subgroup analysis

OBJECTIVE: To evaluate the impact of neutrophil-lymphocyte ratio change after curative surgery for gastric cancer. METHODS: A retrospective analysis of patients with gastric cancer who underwent curative surgery between 2009 and 2017 was performed. A cutoff value was established for the neutrophil-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Szor, Daniel José, Dias, André Roncon, Pereira, Marina Alessandra, Ramos, Marcus Fernando Kodama Pertille, Zilberstein, Bruno, Cecconello, Ivan, Ribeiro, Ulysses
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896601/
https://www.ncbi.nlm.nih.gov/pubmed/31778466
http://dx.doi.org/10.31744/einstein_journal/2020AO4860
Descripción
Sumario:OBJECTIVE: To evaluate the impact of neutrophil-lymphocyte ratio change after curative surgery for gastric cancer. METHODS: A retrospective analysis of patients with gastric cancer who underwent curative surgery between 2009 and 2017 was performed. A cutoff value was established for the neutrophil-lymphocyte ratio in the pre- and postoperative periods, according to the median value, and four subgroups were formed (low-low/low-high/high-low/high-high). Clinical-pathological and survival data were analyzed and related to these subgroups. RESULTS: A total of 325 patients were included in the study. The cutoff values of the neutrophil-lymphocyte ratio were 2.14 and 1.8 for the pre and postoperative periods, respectively. In patients with stages I and II, the high-high subgroup presented worse overall survival (p=0.016) and disease-free survival (p=0.001). Complications were higher in the low-high subgroup of patients. CONCLUSION: The neutrophil-lymphocyte ratio is a low cost, efficient and reproducible marker. The prognosis individualization can be performed according to the identification of subgroups at a higher risk of complications and worse prognosis.